Streetbeat News

Products Services

IMTX

Immatics announced updated Phase 1b data for its ACTengine IMA203 targeting PRAME in melanoma patients, showing promising results in progression-free survival and overall survival. The company plans to proceed to a Phase 3 trial, SUPRAME, set to begin in December 2024.

Portfolio Pulse from Benzinga Newsdesk

October 10, 2024 | 10:36 am

SABR

Riyadh Air has partnered with Sabre to implement SabreMosaic Offer Optimization Technology, making it the first airline to operate on offer- and order-based technology from its inception in 2025.

Portfolio Pulse from Benzinga Newsdesk

October 10, 2024 | 10:33 am

GOOGL

TSLA

UBER

Uber is leveraging its extensive ridesharing network to compete in the robotaxi sector against Tesla and Waymo. Uber's strategy focuses on expanding its marketplace rather than developing autonomous vehicles, providing a cost-effective advantage. Tesla and Waymo face challenges with costly autonomous fleets and regulatory hurdles.

Portfolio Pulse from Benzinga Neuro

October 10, 2024 | 10:33 am

YI

111 has announced the commencement of operations at new fulfillment centers in Guangzhou, Guangdong Province, and Wuhan, Hubei Province, enhancing its logistics capabilities in South and Central China.

Portfolio Pulse from Benzinga Newsdesk

October 10, 2024 | 10:29 am

GOOGL

USO

U.S. markets closed higher due to Federal Reserve minutes indicating support for a rate cut. Tech stocks were mixed, with Alphabet down 1.5% due to antitrust concerns. Crude oil prices surged on supply risks, while U.S. futures and the dollar index showed slight declines.

Portfolio Pulse from Akanksha Bakshi

October 10, 2024 | 10:26 am

LPCN

Lipocine Inc. has reported promising data from its qEEG study of oral brexanolone, showing significant CNS activity and potential for treating various neuropsychiatric conditions. The results support further development of the drug.

Portfolio Pulse from Benzinga Newsdesk

October 10, 2024 | 10:23 am

LPCN

Lipocine announced positive results for its oral Brexanolone, which was well-tolerated with minimal central nervous system depressant effects. This development could be significant for Lipocine's future prospects.

Portfolio Pulse from Benzinga Newsdesk

October 10, 2024 | 10:11 am

INFY

Infosys has partnered with Zooplus, a German e-commerce company, to enhance service capability and scalability by establishing a Global Capability Center in Hyderabad, India.

Portfolio Pulse from Benzinga Newsdesk

October 10, 2024 | 10:11 am

ORLA

Orla Mining has increased its full-year gold production guidance to 130,000-140,000 ounces, up from the revised outlook of 120,000-130,000 ounces in August. The initial annual guidance was 110,000-120,000 ounces.

Portfolio Pulse from Benzinga Newsdesk

October 10, 2024 | 10:06 am

ORLA

Orla Mining reported its Q3 2024 operational results for the Camino Rojo Oxide Mine, producing 43,788 ounces and selling 38,265 ounces of gold. The company also updated its annual production guidance.

Portfolio Pulse from Benzinga Newsdesk

October 10, 2024 | 10:05 am